通过热带重定位的简单疹病毒进行认知性和不可知性免疫治疗,而无需直接治疗瘤
Andrea Vannini1,2, Federico Parenti2, Cristina Forghieri2
1Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Journal for immunotherapy of cancer
|July 23, 2025
概括
这项研究引入了一种新的癌症免疫疗法平台,使用修饰的简单疹病毒 (ReHV) 刺激T细胞对瘤的反应. 通过ReHV介导的免疫治疗平台 (Re-IP) 有效地抑制远程瘤生长,即使在预免疫小鼠中也是如此.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 癌症免疫疗法包括各种不同的疫苗策略,有效性各不相同.
- 全细胞疫苗提供了不可知抗原向,但往往缺乏效力.
- 瘤病毒,包括热带重定位的简单疹病毒 (ReHVs),通过修改瘤微环境来增强抗瘤免疫力.
研究的目的:
- 开发和评估一种新的ReHV介导免疫治疗平台 (Re-IP) 用于癌症治疗.
- 评估Re-IP在没有直接治疗瘤的情况下诱导T细胞对瘤的反应的能力.
主要方法:
- 开发的Re-IP使用了ex vivo感染了HER2-热带ReHV的提米丁酶阳性癌细胞.
- 异位注射受感染细胞以免疫小鼠抵抗癌症.
- 在临床前模型中评估了T细胞原始化,瘤透和生长抑制.
主要成果:
- Re-IP强有力的抗癌T细胞,透和抑制遥远的未经治疗的瘤.
- 瘤生长抑制依赖于CD8+ T细胞,并使瘤对检查点阻塞敏感.
- Re-IP在原先免疫过敏病毒 (HSV) 的小鼠中显示出有效性,并显示出没有异位病毒复制的安全性.
结论:
- 宫外Re-IP的使用增强了癌细胞的免疫性,促进了T细胞对远处瘤的免疫力.
- 这种方法在HSV前免疫环境中有效,并有可能治疗难以接近的或转移性病变.
- 重新IP也可能通过增强免疫细胞激活来增强采用细胞疗法.
更多相关视频
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
17.3K
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.0K
相关概念视频
01:27Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
01:30Cancer Vaccines
516
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
516
01:40Cell-mediated Immune Responses
73.1K
Overview
73.1K
01:29Immune Response Against Viral Pathogens
928
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
928